LINICAL
White Papers
THE LATEST
November 18, 2026
Benefit-risk in early-phase trials: why PV must move from safety oversight to strategic decision partner
As uncertainty defines early-phase clinical development, how can proactive benefit-riskassessment and pharmacovigilance protect patients without...
SIGN UP FOR OUR NEWSLETTER
June 3, 2026
PharmaBoardroom Interview with Dr Toshiaki Nagafuji on the Japanese Clinical Development Landscape in 2026
"Mid-sized CROs like Linical can be suitable partners for relatively small pharmaceutical and biotech companies that are searching for flexibility...
Posts about CRO
September 26, 2024
Taking the Legwork out of Your Clinical Trials
March 15, 2024